Erelzi™ (etanercept-szzs) – New biosimilar approval
August 30, 2016 – The FDA announced the approval of Sandoz’s Erelzi (etanercept-szzs) injection, the third biosimilar product approved in the United States. Erelzi is biosimilar to Enbrel® (etanercept) and shares the same indications.
Download PDF
